XML 18 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended 124 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Cash flows from operating activities:      
Net loss for the period $ (11,226) $ (3,877) $ (35,880)
Adjustments to reconcile loss for the period to net cash used in operations:      
Depreciation and amortization 126 79 1,466
Stock-based compensation 1,012 131 8,072
Gain on disposal of marketable securities (144) (366) (7,946)
Loss on extinguishment of convertible notes 0 0 1,218
Accrued interest and accretion of interest 0 96 4,096
Gain on disposal of mineral property (934) 0 (80,867)
Common stock issued for interest 0 0 1,841
Unrealized (gain) loss on long-term investments 7,365 0 (29,982)
Write down of marketable securities 0 0 1,007
Deferred tax (benefit) expense (2,991) 0 32,531
Other non-cash items 0 0 1,304
Change in working capital account items:      
Other current assets (86) (308) (1,525)
Accrued interest payable 0 0 (8,090)
Accounts payable, accrued liabilities and other (171) (223) 744
Net cash used in operating activities (7,049) (4,468) (112,011)
Cash flows from investing activities:      
Purchases of marketable securities (68) (70) (1,756)
Proceeds from sales of marketable securities 208 392 11,257
Acquisition of long-term investments 0 0 (3,632)
Additions to mineral property   (50) (7,647)
Additions to plant and equipment (342) (29) (20,785)
Change in Restricted Cash (22)   (22)
Proceeds from additional option agreement 1,500 0 2,500
Proceeds from earn in right agreement 2,000   2,000
Proceeds on disposal of mineral property 0 0 188
Proceeds on disposal of plant and equipment 0 0 52
Cash transferred to Allied Nevada Gold Corp., net of receivable 0 0 (24,517)
Net cash provided by/(used in) investing activities 3,276 243 (42,362)
Cash flows from financing activities:      
Net proceeds from equity financings 0 0 137,070
Repayment of convertible notes 0 (23,000) (26,108)
Proceeds from exercise of warrants 733 0 40,062
Proceeds from exercise of stock options 0 73 3,974
Issuance of convertible notes 0 0 28,345
Cash paid in lieu of capital stock issuances 0 0 (107)
Transaction costs 0 0 (1,841)
Net cash provided by/(used in) financing activities 733 (22,927) 181,395
Increase/(decrease) in cash and cash equivalents (3,040) (27,152) 27,022
Decrease in cash and cash equivalents - discontinued operations 0 0 (12,863)
Net increase/(decrease) in cash and cash equivalents (3,040) (27,152) 14,159
Cash and cash equivalents, beginning of period 17,873 39,838 674
Cash and cash equivalents, end of period $ 14,833 $ 12,686 $ 14,833